ÂÜÀòÂÒÂ×

The Medical and Clinical Teams at Geron are responsible for the development, clinical evaluation, and potential commercialization of imetelstat, a telomerase inhibitor targeting hematologic myeloid malignancies. Their duties include designing and overseeing clinical trials, analyzing clinical data, ensuring regulatory compliance, developing scientific communications, managing patient services and medical affairs, and strategizing real-world evidence and field medical operations to support the drug's pathway from trials to market.